Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.

Whop LJ, Baade P, Garvey G, Cunningham J, Brotherton JM, Lokuge K, Valery PC, O'Connell DL, Canfell K, Diaz A, Roder D, Gertig DM, Moore SP, Condon JR.

PLoS One. 2016 Apr 11;11(4):e0150473. doi: 10.1371/journal.pone.0150473. eCollection 2016.

2.

TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.

Koeneman MM, Kruse AJ, Kooreman LF, Zur Hausen A, Hopman AH, Sep SJ, Van Gorp T, Slangen BF, van Beekhuizen HJ, van de Sande M, Gerestein CG, Nijman HW, Kruitwagen RF.

BMC Cancer. 2016 Feb 20;16(1):132. doi: 10.1186/s12885-016-2187-3.

4.

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.

Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström KM, Arnheim-Dahlström L, Dillner J, Sparén P.

BMJ. 2016 Feb 11;352:i276. doi: 10.1136/bmj.i276.

5.

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection.

Cullen M, Boland JF, Schiffman M, Zhang X, Wentzensen N, Yang Q, Chen Z, Yu K, Mitchell J, Roberson D, Bass S, Burdette L, Machado M, Ravichandran S, Luke B, Machiela MJ, Andersen M, Osentoski M, Laptewicz M, Wacholder S, Feldman A, Raine-Bennett T, Lorey T, Castle PE, Yeager M, Burk RD, Mirabello L.

Papillomavirus Res. 2015 Dec 1;1:3-11.

PMID:
26645052
6.

Triage of HPV positive women in cervical cancer screening.

Wentzensen N, Schiffman M, Palmer T, Arbyn M.

J Clin Virol. 2016 Mar;76 Suppl 1:S49-55. doi: 10.1016/j.jcv.2015.11.015. Epub 2015 Nov 28. Review.

PMID:
26643050
7.

CIN III lesions and regression: retrospective analysis of 635 cases.

Motamedi M, Böhmer G, Neumann HH, von Wasielewski R.

BMC Infect Dis. 2015 Nov 21;15:541. doi: 10.1186/s12879-015-1277-1.

8.

HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma.

Xue Y, Toh SY, He P, Lim T, Lim D, Pang CL, Abastado JP, Thierry F.

Oncotarget. 2015 Oct 27;6(33):34979-91. doi: 10.18632/oncotarget.5512.

9.

The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.

Hestbech MS, Lynge E, Kragstrup J, Siersma V, Vazquez-Prada Baillet M, Brodersen J.

BMJ Open. 2015 Aug 14;5(8):e007921. doi: 10.1136/bmjopen-2015-007921.

10.

A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.

Guerrero AM, Genuino AJ, Santillan M, Praditsitthikorn N, Chantarastapornchit V, Teerawattananon Y, Alejandria M, Toral JA.

BMC Public Health. 2015 Jul 30;15:730. doi: 10.1186/s12889-015-2046-1.

11.

Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study.

Del Mistro A, Matteucci M, Insacco EA, Onnis G, Da Re F, Baboci L, Zorzi M, Minucci D.

Biomed Res Int. 2015;2015:984528. doi: 10.1155/2015/984528. Epub 2015 Jun 9.

12.

Targeting female hormone receptors as cervical cancer therapy.

Chung SH.

Trends Endocrinol Metab. 2015 Aug;26(8):399-401. doi: 10.1016/j.tem.2015.06.004. Epub 2015 Jul 9.

PMID:
26163756
13.

Distribution of cervical intraepithelial neoplasia on the cervix in Chinese women: pooled analysis of 19 population based screening studies.

Zhao YQ, Chang IJ, Zhao FH, Hu SY, Smith JS, Zhang X, Li SM, Bai P, Zhang WH, Qiao YL.

BMC Cancer. 2015 Jun 27;15:485. doi: 10.1186/s12885-015-1494-4.

14.

HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures.

Pickard A, McDade SS, McFarland M, McCluggage WG, Wheeler CM, McCance DJ.

PLoS Pathog. 2015 Jun 24;11(6):e1004988. doi: 10.1371/journal.ppat.1004988. eCollection 2015 Jun.

15.

Screening for Anal Cancer in Women.

Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, Chiao E, Einstein MH, Goldstone SE, Jay N, Likes WM, Stier EA, Welton ML, Wiley DJ, Palefsky JM.

J Low Genit Tract Dis. 2015 Jul;19(3 Suppl 1):S27-42. doi: 10.1097/LGT.0000000000000117. Review.

PMID:
26103446
16.
17.
18.

Clinical significance of HPV-DNA testing for precancerous cervical lesions.

Moarcăs M, Georgescu IC, Brătilă E, Badea M, Cîrstoiu M.

J Med Life. 2014;7 Spec No. 3:37-9.

19.

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS.

Cancer Cytopathol. 2015 May;123(5):282-8. doi: 10.1002/cncy.21544. Epub 2015 Apr 10.

20.

c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.

Kübler K, Heinenberg S, Rudlowski C, Keyver-Paik MD, Abramian A, Merkelbach-Bruse S, Büttner R, Kuhn W, Schildhaus HU.

Oncotarget. 2015 Jan 20;6(2):825-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk